Opioid Use Disorder Clinical Trials in Minneapolis, Minnesota

6 studies are recruiting for opioid use disorder in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

   The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation of office-based met…

   Stage

   Phase 4

   Ages

   18 to 99

   Site

   Hennepin Healthcare Addiction Medicine, Minneapolis, Minnesota

   Locations

   6 in total

   Run by

   Yale University

   See if you can join NCT06323824 on ClinicalTrials.gov

2. Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial

   The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspective…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Clinic Site C (blinded pending tribal approval), Minneapolis, Minnesota

   Locations

   3 in total

   Run by

   University of New Mexico

   See if you can join NCT06565416 on ClinicalTrials.gov

3. A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

   VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous formulation of buprenorphine at a target dose of 300 milligrams (mg) is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence compared to the daily sublingual (under the tongue) buprenorph…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota

   Locations

   25 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT04375033 on ClinicalTrials.gov

4. EMS-Initiated Buprenorphine

   This is a multisite EMS study that will first conduct a sequence of pragmatic, prehospital field studies to provide preliminary feasibility, acceptability, and safety data for refinement and enhancement of a subsequent single-arm prospective trial that will provide preliminary effectiveness data, f…

   Stage

   Not phased

   Ages

   Any age

   Site

   Hennepin Healthcare, Minneapolis, Minnesota

   Locations

   3 in total

   Run by

   Yale University

   See if you can join NCT07475728 on ClinicalTrials.gov

5. Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

   The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of Minnesota, Minneapolis, Minnesota

   Run by

   University of Minnesota

   See if you can join NCT07158853 on ClinicalTrials.gov

6. Brain Training for Substance Use Disorders

   Participants play games designed to train visual attention towards natural, non-drug-related scenarios. A biofeedback loop between gameplay and an electroencephalogram (EEG) system monitors game performance and guides game difficulty.

   Stage

   Not phased

   Ages

   18 to 65

   Site

   University of Minnesota - Department of Psychiatry & Behavioral Health, Minneapolis, Minnesota

   Run by

   Neurotype Inc.

   See if you can join NCT06870110 on ClinicalTrials.gov